Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry Developments

Top Articles
:

Nigeria

BMI View: Medicines demand in Nigeria will be driven by urbanisation, rising per capita incomes, a growing burden on non-communicable diseases and the government's plans to increase... 2013-10-09


Nigeria

BMI View: Medicines demand in Nigeria will be driven by urbanisation, rising per capita incomes, a growing burden on non-communicable diseases and the government's plans to increase... 2013-10-09


United Arab Emirates

The demographic profile of the emirate of Dubai is not conducive to widespread healthcare insurance uptake. The population is young – with 50% of residents between the ages... 2013-10-07


More ARTICLES

Geographic diversification may be a favourable strategy for multinational pharmaceutical companies, but it is vital that firms recognise both the rewards and the risks present in a... 2013-10-04


Government-imposed downward pressure on innovative medicine prices in Gulf Cooperation Council countries is a key risk to multinationals looking to maximise commercial opportunities... 2013-10-04


Egypt

The Egyptian Drug Authority's complex organisational structure, with various sub-organisations and committees, makes for a difficult drug registration process for local and foreign... 2013-10-03


Gulf Cooperation Council (GCC) countries are currently the most attractive to multinationals launching new products in the Middle East and Africa. In addition to intellectual property... 2013-08-16


United Arab Emirates

African countries offer significant revenue-generating opportunities for drugmakers over the long term, as their developing economies will yield growing middle class populations, urbanisation... 2013-08-14

Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries